Skip to main content
FinSpry Logo
FinSpry
SPRY logo
SPRY
(NASDAQ)
ARS Pharmaceuticals, Inc.
$8.30-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

ARS Pharmaceuticals (SPRY) Stock Price & Financial Analysis

ARS Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$7.72 - $8.31
52-Week High$18.90
52-Week Low$6.66
Open$7.91
Volume1.28M
Average Volume (3M)1.28M
Market Cap818.10M
Shares Outstanding98.57M
Price to Sales (P/S)9.48
Price to Book (P/B)7.00
EV/EBITDA-4.13
Revenue (TTM)84.28M
Net Income (TTM)-171.30M
Free Cash Flow (TTM)-171.21M
EPS (TTM)$-1.74
Profit Margin-203.25%
Operating Margin-212.92%
Return on Equity (ROE)-149.92%
Debt to Equity0.00
50-Day MA$9.15
200-Day MA$11.50
52-Week Change-35.28%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About ARS Pharmaceuticals

What is the current stock price for SPRY?

As of the latest trading session, SPRY stock trades at $8.30. The 52-week range is $6.66–$18.90, with a day range of $7.72–$8.31.

What is the P/E ratio for SPRY?

The P/E ratio (Price-to-Earnings) for SPRY is shown in the Key Statistics section. This valuation metric helps compare ARS Pharmaceuticals, Inc. to industry peers.

Does SPRY pay dividends?

ARS Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for SPRY?

Analyst ratings and recommendations for SPRY are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of SPRY?

ARS Pharmaceuticals's market capitalization is $818.1M, classifying it as a small-cap company. ARS Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.